New Drugs Act: What's in store for Indian drug industry?

Excerpts from Power Breakfast on CNBC-TV18 Watch the full show » RELATED NEWS Govt to replace drug price control system: Sources Nifty BSE | NSE 25/05/12 Are Mutual Funds betting on Nifty?

CNBC-TV18 has obtained a copy of the draft Drugs Act, which arms the government with sweeping powers over drug prices. CNBC-TV18's exclusive report on what's in store for the Indian drug industry.

 

Medicines are sure to become more affordable for Indians. The government is arming itself with the power to regulate prices of drugs, and not only those produced in the country but also imported drugs in segments such as cancer and heart diseases.

 

It plans to do this by bringing in a legislation to control drug prices. CNBC-TV18 learns that a new Act called the Drugs Price Regulation and Control Act has been drafted. This would replace the current system of price orders issued under the Essential Commodities Act.

 

The intention is clearly to ensure that patented drugs meet the health care needs of the nation and are made affordable. This move seems intended to curb the profit motive of unscrupulous producers.

 

The new Act will empower the government to seek cost data of all drugs, whether manufactured domestically or abroad. The Draft Act also proposes that patented drugs can only be sold after companies negotiate prices with the government. The negotiated price will then be the maximum selling price including taxes.

 

Contd on Pg 2...